Mackay Shields LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-20,735
| Closed | -$2.36M | – | 1182 |
|
|
2021
Q1 | $2.36M | Sell |
20,735
-12,836
| -38% | -$1.46M | 0.02% | 699 |
|
|
2020
Q4 | $4.65M | Sell |
33,571
-4,500
| -12% | -$623K | 0.03% | 506 |
|
|
2020
Q3 | $3.13M | Sell |
38,071
-5,100
| -12% | -$419K | 0.02% | 597 |
|
|
2020
Q2 | $3.38M | Buy |
43,171
+3,200
| +8% | +$250K | 0.03% | 526 |
|
|
2020
Q1 | $1.78M | Sell |
39,971
-6,400
| -14% | -$284K | 0.02% | 714 |
|
|
2019
Q4 | $1.98M | Sell |
46,371
-600
| -1% | -$25.6K | 0.01% | 878 |
|
|
2019
Q3 | $2.01M | Sell |
46,971
-800
| -2% | -$34.2K | 0.01% | 899 |
|
|
2019
Q2 | $3.03M | Buy |
47,771
+30,836
| +182% | +$1.96M | 0.02% | 753 |
|
|
2019
Q1 | $1.17M | Buy |
16,935
+1,300
| +8% | +$90.1K | 0.01% | 945 |
|
|
2018
Q4 | $679K | Sell |
15,635
-1,663
| -10% | -$72.2K | 0.01% | 1061 |
|
|
2018
Q3 | $1.32M | Buy |
17,298
+1,900
| +12% | +$145K | 0.01% | 815 |
|
|
2018
Q2 | $1.18M | Sell |
15,398
-300
| -2% | -$23K | 0.01% | 907 |
|
|
2018
Q1 | $800K | Buy |
+15,698
| New | +$800K | 0.01% | 1030 |
|